Volume XXII, Number 18 – December 28, 2015
In this issue:
DURING 2015, TWO STORIES captured the full attention of most pathologists and clinical lab managers. One was how CMS intends to gather lab price market data as mandated by PAMA — a move that the industry is protesting via Congress, as reported in this issue. The other was the continued efforts by the FDA to move ahead on proposed guidance for regulation of LDTs. Meanwhile, the full list of THE DARK REPORT’s “Top 10 Lab Industry Stories for 2015” includes additional developments with the potential to radically change the lab industry as it operates today.